 | • レポートコード：MRC2-11QY11037 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は良性前立腺肥大症検査のグローバル市場について調査・分析したレポートです。種類別（尿検査、前立腺特異抗原（PSA）血液検査、尿流動態検査、膀胱鏡検査）市場規模、用途別（病院、診断センター、クリニック、研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別良性前立腺肥大症検査の競争状況、市場シェア ・世界の良性前立腺肥大症検査市場：種類別市場規模 2015年-2020年（尿検査、前立腺特異抗原（PSA）血液検査、尿流動態検査、膀胱鏡検査） ・世界の良性前立腺肥大症検査市場：種類別市場規模予測 2021年-2026年（尿検査、前立腺特異抗原（PSA）血液検査、尿流動態検査、膀胱鏡検査） ・世界の良性前立腺肥大症検査市場：用途別市場規模 2015年-2020年（病院、診断センター、クリニック、研究所） ・世界の良性前立腺肥大症検査市場：用途別市場規模予測 2021年-2026年（病院、診断センター、クリニック、研究所） ・北米の良性前立腺肥大症検査市場分析：米国、カナダ ・ヨーロッパの良性前立腺肥大症検査市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの良性前立腺肥大症検査市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の良性前立腺肥大症検査市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの良性前立腺肥大症検査市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AEternaZentaris、Astellas Pharma、Eli Lilly and Company、IntelGenx Technologies Corp、Nymox Pharmaceutical Corporation、Protox Therapeutics、Quest PharmaTech ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Benign prostatic hyperplasia (BPH) is a condition occurring in men when the prostate gland is enlarged. Benign prostatic hyperplasia is also termed as benign prostatic hypertrophy or benign prostatic obstruction. Prostate gland grows in primarily two phases, firstly during puberty when the size of the prostate doubles and the second growth phase starts at 25 years and continues throughout the lifetime. While the prostate gland enlarges in a man, it presses and pinches the urethra making the bladder wall thick. This pressure and squeeze on the urethra weaken the bladder and makes it lose the ability to empty the urine completely. Urinary retention and narrowing of the urethra can cause many problems which are associated with benign prostatic hyperplasia. Benign prostatic hyperplasia is one of the common prostate problems for men older than age 50.
Benign prostatic hyperplasia testing market is primarily driven by a few key factors such as the growing geriatric male population, patient awareness regarding rising healthcare concerns, increase in healthcare expenditure, increasing government initiatives and availability of minimally invasive surgery as a drug replacement, faster and easy performing diagnosis test results. The market is likely to grow owing to the novel diagnostic methods which are accurate than the conventional PSA blood test for benign prostatic hyperplasia which is effective in diagnosis and is expected to fuel the growth of benign prostatic hyperplasia testing market.
Market Analysis and Insights: Global Benign Prostatic Hyperplasia Testing Market
The global Benign Prostatic Hyperplasia Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Benign Prostatic Hyperplasia Testing Scope and Market Size
Benign Prostatic Hyperplasia Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Benign Prostatic Hyperplasia Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
AEternaZentaris
Astellas Pharma
Eli Lilly and Company
IntelGenx Technologies Corp
Nymox Pharmaceutical Corporation
Protox Therapeutics
Quest PharmaTech
…
Market segment by Type, the product can be split into
Urinalysis
Prostate-Specific Antigen (PSA) Blood Test
Urodynamic Test
Cystoscopy
Market segment by Application, split into
Hospitals
Diagnostic Centers
Clinics
Research Institutes
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Benign Prostatic Hyperplasia Testing Revenue
1.4 Market by Type
1.4.1 Global Benign Prostatic Hyperplasia Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Urinalysis
1.4.3 Prostate-Specific Antigen (PSA) Blood Test
1.4.4 Urodynamic Test
1.4.5 Cystoscopy
1.5 Market by Application
1.5.1 Global Benign Prostatic Hyperplasia Testing Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Diagnostic Centers
1.5.4 Clinics
1.5.5 Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Benign Prostatic Hyperplasia Testing Market Perspective (2015-2026)
2.2 Global Benign Prostatic Hyperplasia Testing Growth Trends by Regions
2.2.1 Benign Prostatic Hyperplasia Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Benign Prostatic Hyperplasia Testing Historic Market Share by Regions (2015-2020)
2.2.3 Benign Prostatic Hyperplasia Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Benign Prostatic Hyperplasia Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Benign Prostatic Hyperplasia Testing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Benign Prostatic Hyperplasia Testing Players by Market Size
3.1.1 Global Top Benign Prostatic Hyperplasia Testing Players by Revenue (2015-2020)
3.1.2 Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Benign Prostatic Hyperplasia Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Benign Prostatic Hyperplasia Testing Market Concentration Ratio
3.2.1 Global Benign Prostatic Hyperplasia Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Benign Prostatic Hyperplasia Testing Revenue in 2019
3.3 Benign Prostatic Hyperplasia Testing Key Players Head office and Area Served
3.4 Key Players Benign Prostatic Hyperplasia Testing Product Solution and Service
3.5 Date of Enter into Benign Prostatic Hyperplasia Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Benign Prostatic Hyperplasia Testing Historic Market Size by Type (2015-2020)
4.2 Global Benign Prostatic Hyperplasia Testing Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Benign Prostatic Hyperplasia Testing Market Size by Application (2015-2020)
5.2 Global Benign Prostatic Hyperplasia Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Benign Prostatic Hyperplasia Testing Market Size (2015-2020)
6.2 Benign Prostatic Hyperplasia Testing Key Players in North America (2019-2020)
6.3 North America Benign Prostatic Hyperplasia Testing Market Size by Type (2015-2020)
6.4 North America Benign Prostatic Hyperplasia Testing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Benign Prostatic Hyperplasia Testing Market Size (2015-2020)
7.2 Benign Prostatic Hyperplasia Testing Key Players in Europe (2019-2020)
7.3 Europe Benign Prostatic Hyperplasia Testing Market Size by Type (2015-2020)
7.4 Europe Benign Prostatic Hyperplasia Testing Market Size by Application (2015-2020)
8 China
8.1 China Benign Prostatic Hyperplasia Testing Market Size (2015-2020)
8.2 Benign Prostatic Hyperplasia Testing Key Players in China (2019-2020)
8.3 China Benign Prostatic Hyperplasia Testing Market Size by Type (2015-2020)
8.4 China Benign Prostatic Hyperplasia Testing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Benign Prostatic Hyperplasia Testing Market Size (2015-2020)
9.2 Benign Prostatic Hyperplasia Testing Key Players in Japan (2019-2020)
9.3 Japan Benign Prostatic Hyperplasia Testing Market Size by Type (2015-2020)
9.4 Japan Benign Prostatic Hyperplasia Testing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Benign Prostatic Hyperplasia Testing Market Size (2015-2020)
10.2 Benign Prostatic Hyperplasia Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Benign Prostatic Hyperplasia Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Benign Prostatic Hyperplasia Testing Market Size by Application (2015-2020)
11 India
11.1 India Benign Prostatic Hyperplasia Testing Market Size (2015-2020)
11.2 Benign Prostatic Hyperplasia Testing Key Players in India (2019-2020)
11.3 India Benign Prostatic Hyperplasia Testing Market Size by Type (2015-2020)
11.4 India Benign Prostatic Hyperplasia Testing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Benign Prostatic Hyperplasia Testing Market Size (2015-2020)
12.2 Benign Prostatic Hyperplasia Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Benign Prostatic Hyperplasia Testing Market Size by Type (2015-2020)
12.4 Central & South America Benign Prostatic Hyperplasia Testing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AEternaZentaris
13.1.1 AEternaZentaris Company Details
13.1.2 AEternaZentaris Business Overview
13.1.3 AEternaZentaris Benign Prostatic Hyperplasia Testing Introduction
13.1.4 AEternaZentaris Revenue in Benign Prostatic Hyperplasia Testing Business (2015-2020))
13.1.5 AEternaZentaris Recent Development
13.2 Astellas Pharma
13.2.1 Astellas Pharma Company Details
13.2.2 Astellas Pharma Business Overview
13.2.3 Astellas Pharma Benign Prostatic Hyperplasia Testing Introduction
13.2.4 Astellas Pharma Revenue in Benign Prostatic Hyperplasia Testing Business (2015-2020)
13.2.5 Astellas Pharma Recent Development
13.3 Eli Lilly and Company
13.3.1 Eli Lilly and Company Company Details
13.3.2 Eli Lilly and Company Business Overview
13.3.3 Eli Lilly and Company Benign Prostatic Hyperplasia Testing Introduction
13.3.4 Eli Lilly and Company Revenue in Benign Prostatic Hyperplasia Testing Business (2015-2020)
13.3.5 Eli Lilly and Company Recent Development
13.4 IntelGenx Technologies Corp
13.4.1 IntelGenx Technologies Corp Company Details
13.4.2 IntelGenx Technologies Corp Business Overview
13.4.3 IntelGenx Technologies Corp Benign Prostatic Hyperplasia Testing Introduction
13.4.4 IntelGenx Technologies Corp Revenue in Benign Prostatic Hyperplasia Testing Business (2015-2020)
13.4.5 IntelGenx Technologies Corp Recent Development
13.5 Nymox Pharmaceutical Corporation
13.5.1 Nymox Pharmaceutical Corporation Company Details
13.5.2 Nymox Pharmaceutical Corporation Business Overview
13.5.3 Nymox Pharmaceutical Corporation Benign Prostatic Hyperplasia Testing Introduction
13.5.4 Nymox Pharmaceutical Corporation Revenue in Benign Prostatic Hyperplasia Testing Business (2015-2020)
13.5.5 Nymox Pharmaceutical Corporation Recent Development
13.6 Protox Therapeutics
13.6.1 Protox Therapeutics Company Details
13.6.2 Protox Therapeutics Business Overview
13.6.3 Protox Therapeutics Benign Prostatic Hyperplasia Testing Introduction
13.6.4 Protox Therapeutics Revenue in Benign Prostatic Hyperplasia Testing Business (2015-2020)
13.6.5 Protox Therapeutics Recent Development
13.7 Quest PharmaTech
13.7.1 Quest PharmaTech Company Details
13.7.2 Quest PharmaTech Business Overview
13.7.3 Quest PharmaTech Benign Prostatic Hyperplasia Testing Introduction
13.7.4 Quest PharmaTech Revenue in Benign Prostatic Hyperplasia Testing Business (2015-2020)
13.7.5 Quest PharmaTech Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Benign Prostatic Hyperplasia Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Benign Prostatic Hyperplasia Testing Revenue
Table 3. Ranking of Global Top Benign Prostatic Hyperplasia Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Benign Prostatic Hyperplasia Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Urinalysis
Table 6. Key Players of Prostate-Specific Antigen (PSA) Blood Test
Table 7. Key Players of Urodynamic Test
Table 8. Key Players of Cystoscopy
Table 9. Global Benign Prostatic Hyperplasia Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Benign Prostatic Hyperplasia Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Benign Prostatic Hyperplasia Testing Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Benign Prostatic Hyperplasia Testing Market Share by Regions (2015-2020)
Table 13. Global Benign Prostatic Hyperplasia Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Benign Prostatic Hyperplasia Testing Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Benign Prostatic Hyperplasia Testing Market Growth Strategy
Table 19. Main Points Interviewed from Key Benign Prostatic Hyperplasia Testing Players
Table 20. Global Benign Prostatic Hyperplasia Testing Revenue by Players (2015-2020) (Million US$)
Table 21. Global Benign Prostatic Hyperplasia Testing Market Share by Players (2015-2020)
Table 22. Global Top Benign Prostatic Hyperplasia Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Benign Prostatic Hyperplasia Testing as of 2019)
Table 23. Global Benign Prostatic Hyperplasia Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Benign Prostatic Hyperplasia Testing Product Solution and Service
Table 26. Date of Enter into Benign Prostatic Hyperplasia Testing Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Benign Prostatic Hyperplasia Testing Market Size by Type (2015-2020) (Million US$)
Table 29. Global Benign Prostatic Hyperplasia Testing Market Size Share by Type (2015-2020)
Table 30. Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Type (2021-2026)
Table 31. Global Benign Prostatic Hyperplasia Testing Market Size Share by Application (2015-2020)
Table 32. Global Benign Prostatic Hyperplasia Testing Market Size by Application (2015-2020) (Million US$)
Table 33. Global Benign Prostatic Hyperplasia Testing Market Size Share by Application (2021-2026)
Table 34. North America Key Players Benign Prostatic Hyperplasia Testing Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Benign Prostatic Hyperplasia Testing Market Share (2019-2020)
Table 36. North America Benign Prostatic Hyperplasia Testing Market Size by Type (2015-2020) (Million US$)
Table 37. North America Benign Prostatic Hyperplasia Testing Market Share by Type (2015-2020)
Table 38. North America Benign Prostatic Hyperplasia Testing Market Size by Application (2015-2020) (Million US$)
Table 39. North America Benign Prostatic Hyperplasia Testing Market Share by Application (2015-2020)
Table 40. Europe Key Players Benign Prostatic Hyperplasia Testing Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Benign Prostatic Hyperplasia Testing Market Share (2019-2020)
Table 42. Europe Benign Prostatic Hyperplasia Testing Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Benign Prostatic Hyperplasia Testing Market Share by Type (2015-2020)
Table 44. Europe Benign Prostatic Hyperplasia Testing Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Benign Prostatic Hyperplasia Testing Market Share by Application (2015-2020)
Table 46. China Key Players Benign Prostatic Hyperplasia Testing Revenue (2019-2020) (Million US$)
Table 47. China Key Players Benign Prostatic Hyperplasia Testing Market Share (2019-2020)
Table 48. China Benign Prostatic Hyperplasia Testing Market Size by Type (2015-2020) (Million US$)
Table 49. China Benign Prostatic Hyperplasia Testing Market Share by Type (2015-2020)
Table 50. China Benign Prostatic Hyperplasia Testing Market Size by Application (2015-2020) (Million US$)
Table 51. China Benign Prostatic Hyperplasia Testing Market Share by Application (2015-2020)
Table 52. Japan Key Players Benign Prostatic Hyperplasia Testing Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Benign Prostatic Hyperplasia Testing Market Share (2019-2020)
Table 54. Japan Benign Prostatic Hyperplasia Testing Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Benign Prostatic Hyperplasia Testing Market Share by Type (2015-2020)
Table 56. Japan Benign Prostatic Hyperplasia Testing Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Benign Prostatic Hyperplasia Testing Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Benign Prostatic Hyperplasia Testing Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Benign Prostatic Hyperplasia Testing Market Share (2019-2020)
Table 60. Southeast Asia Benign Prostatic Hyperplasia Testing Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Benign Prostatic Hyperplasia Testing Market Share by Type (2015-2020)
Table 62. Southeast Asia Benign Prostatic Hyperplasia Testing Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Benign Prostatic Hyperplasia Testing Market Share by Application (2015-2020)
Table 64. India Key Players Benign Prostatic Hyperplasia Testing Revenue (2019-2020) (Million US$)
Table 65. India Key Players Benign Prostatic Hyperplasia Testing Market Share (2019-2020)
Table 66. India Benign Prostatic Hyperplasia Testing Market Size by Type (2015-2020) (Million US$)
Table 67. India Benign Prostatic Hyperplasia Testing Market Share by Type (2015-2020)
Table 68. India Benign Prostatic Hyperplasia Testing Market Size by Application (2015-2020) (Million US$)
Table 69. India Benign Prostatic Hyperplasia Testing Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Benign Prostatic Hyperplasia Testing Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Benign Prostatic Hyperplasia Testing Market Share (2019-2020)
Table 72. Central & South America Benign Prostatic Hyperplasia Testing Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Benign Prostatic Hyperplasia Testing Market Share by Type (2015-2020)
Table 74. Central & South America Benign Prostatic Hyperplasia Testing Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Benign Prostatic Hyperplasia Testing Market Share by Application (2015-2020)
Table 76. AEternaZentaris Company Details
Table 77. AEternaZentaris Business Overview
Table 78. AEternaZentaris Product
Table 79. AEternaZentaris Revenue in Benign Prostatic Hyperplasia Testing Business (2015-2020) (Million US$)
Table 80. AEternaZentaris Recent Development
Table 81. Astellas Pharma Company Details
Table 82. Astellas Pharma Business Overview
Table 83. Astellas Pharma Product
Table 84. Astellas Pharma Revenue in Benign Prostatic Hyperplasia Testing Business (2015-2020) (Million US$)
Table 85. Astellas Pharma Recent Development
Table 86. Eli Lilly and Company Company Details
Table 87. Eli Lilly and Company Business Overview
Table 88. Eli Lilly and Company Product
Table 89. Eli Lilly and Company Revenue in Benign Prostatic Hyperplasia Testing Business (2015-2020) (Million US$)
Table 90. Eli Lilly and Company Recent Development
Table 91. IntelGenx Technologies Corp Company Details
Table 92. IntelGenx Technologies Corp Business Overview
Table 93. IntelGenx Technologies Corp Product
Table 94. IntelGenx Technologies Corp Revenue in Benign Prostatic Hyperplasia Testing Business (2015-2020) (Million US$)
Table 95. IntelGenx Technologies Corp Recent Development
Table 96. Nymox Pharmaceutical Corporation Company Details
Table 97. Nymox Pharmaceutical Corporation Business Overview
Table 98. Nymox Pharmaceutical Corporation Product
Table 99. Nymox Pharmaceutical Corporation Revenue in Benign Prostatic Hyperplasia Testing Business (2015-2020) (Million US$)
Table 100. Nymox Pharmaceutical Corporation Recent Development
Table 101. Protox Therapeutics Company Details
Table 102. Protox Therapeutics Business Overview
Table 103. Protox Therapeutics Product
Table 104. Protox Therapeutics Revenue in Benign Prostatic Hyperplasia Testing Business (2015-2020) (Million US$)
Table 105. Protox Therapeutics Recent Development
Table 106. Quest PharmaTech Company Details
Table 107. Quest PharmaTech Business Overview
Table 108. Quest PharmaTech Product
Table 109. Quest PharmaTech Revenue in Benign Prostatic Hyperplasia Testing Business (2015-2020) (Million US$)
Table 110. Quest PharmaTech Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Benign Prostatic Hyperplasia Testing Market Share by Type: 2020 VS 2026
Figure 2. Urinalysis Features
Figure 3. Prostate-Specific Antigen (PSA) Blood Test Features
Figure 4. Urodynamic Test Features
Figure 5. Cystoscopy Features
Figure 6. Global Benign Prostatic Hyperplasia Testing Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. Clinics Case Studies
Figure 10. Research Institutes Case Studies
Figure 11. Benign Prostatic Hyperplasia Testing Report Years Considered
Figure 12. Global Benign Prostatic Hyperplasia Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Benign Prostatic Hyperplasia Testing Market Share by Regions: 2020 VS 2026
Figure 14. Global Benign Prostatic Hyperplasia Testing Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Benign Prostatic Hyperplasia Testing Market Share by Players in 2019
Figure 17. Global Top Benign Prostatic Hyperplasia Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Benign Prostatic Hyperplasia Testing as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Benign Prostatic Hyperplasia Testing Revenue in 2019
Figure 19. North America Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
良性前立腺肥大症の世界市場（～2026年） Benign prostatic hyperplasia (BPH) also known as benign prostatic hypertrophy is characterized by the unusual propagation of the prostatic cells, which causes difficulties like urinary retention and infections of the urinary tract. It is most common among the aging men population, primarily driving …- 血液ウイルス検査の世界市場（～2026年） Viral testing is carried out to detect infections caused by viruses by destroying cells of immune system. Viruses breed only in living cells and cause diseases by destructing or injuring the cells they infect, damaging the body's whole immune system, altering the genetic material (DNA) of the cells …
- 血液検査の世界市場（～2026年） A blood test is the analysis of blood sample performed in a laboratory and the blood is usually taken from the vein in the arm through a needle, or through a finger prick to determine patient’s health status. Blood tests are very often used in health care to understand biochemical and physiological …
- 免疫タンパク質診断検査の世界市場（～2026年） Immunoprotein is an immunologically active protein, which provides immunity against pathogenic organisms or substances. These proteins form the integrated body system of tissues, organs, cells, or cell products that neutralize antigens. They enable the diagnosis of various diseases, such as cardiova…
- 尿検査の世界市場（～2026年） Urinalysis is a urine test to detect and manage disorders such as urinary tract infections (UTIs), liver disease, kidney disease, and diabetes. The Americas is the largest market for urinalysis test owing to the rising demand for automated urine analyzers, technological advancement, and rising preva…